08:00 , Dec 8, 2014 |  BC Week In Review  |  Company News

Enigma Diagnostics, Beijing Leadman Biochemistry deal

Enigma and Beijing Leadman formed a JV to provide Enigma’s Enigma Mini Laboratory (Enigma ML) instrument, a real-time point-of-care (POC) PCR amplification and detection system, in China. Enigma will grant exclusive, Chinese rights to its...
08:00 , Jan 14, 2013 |  BioCentury  |  Finance

Darwin's delight

The biotech ecosystem looks healthy moving into 2013. With the space above $1 billion more than replenished in 2012, mid-cap names have money to create their own tier-jumping stories this year, while investors see natural...
07:00 , Oct 1, 2012 |  BioCentury  |  Finance

4Q Financial Markets Preview: Bellwether's ball

For only the second time since 2000, the BioCentury 100 index has matched or beaten the S&P 500 for four consecutive quarters, with most of the gains driven by the bellwether names. Buysiders are cautiously...
07:00 , Aug 6, 2012 |  BioCentury  |  Finance

Glint of IPO optimism

Aftermarket performance is better for biotech IPOs this year than it was in 2011. Although the basics of what it takes to get an IPO done haven't changed - deals routinely continue to require a...
07:00 , Jul 2, 2012 |  BioCentury  |  Finance

3Q Financial Markets Preview: Avoiding burnout

A slew of milestones through year end combined with last quarter's outperformance have investors hopeful that the biotech sector can continue to fend off a dreary macroeconomic environment and weakness in the broader markets. Buysiders...
07:00 , Apr 2, 2012 |  BioCentury  |  Finance

Some like it hot

Despite signs the biotech rally is getting "toppy," market watchers ranging from buysiders to bankers to technical analysts think it can continue into this quarter. They say the market still has momentum and investors still...
08:00 , Feb 20, 2012 |  BC Week In Review  |  Financial News

Beijing Leadman Biochemistry completes IPO

Beijing Leadman Biochemistry Co. Ltd. (SZSE:300289), Beijing, China   Business: Diagnostic, Supply/Service   Date completed: 2/7/12   Type: IPO   Raised: RMB499.2 million ($79.3 million)   Shares: 38.4 million   Price: RMB13  ...
01:40 , Feb 18, 2012 |  BC Extra  |  Financial News

Leadman Biochemistry raises $79.3M in IPO

Beijing Leadman Biochemistry Co. Ltd. (SZSE:300289) raised RMB499.2 million ($79.3 million) through the sale of 38.4 million shares at RMB13 in an IPO on the Shenzhen Stock Exchange. Leadman markets IVD reagents, medical devices and...